Literature DB >> 15234118

Protein kinase CK2 phosphorylates BAD at threonine-117.

Susanne Klumpp1, Anette Mäurer, Yuan Zhu, Dagmar Aichele, Lorenzo A Pinna, Josef Krieglstein.   

Abstract

Reversible phosphorylation of the 22 kDa BAD protein is crucial for cell survival. Five phosphorylation sites, all serines, had been identified. Here we report on number six. It is threonine-117 phosphorylated by the constitutively active kinase, CK2. Phosphoamino acid analysis and phospho-specific antibodies confirmed Thr117 as additional phosphorylation site. Immunoprecipitation furthermore revealed that BAD is phosphorylated at Thr117 in cultured cortical neurons. PP1, PP2A and PP2C dephosphorylated BAD at Thr117, but PP2B did not. The discovery of the constitutively active CK2 phosphorylating BAD is shedding an unexpected light in the otherwise strictly signal-regulated phosphorylation events on BAD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15234118     DOI: 10.1016/j.neuint.2004.02.006

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  8 in total

1.  Hemoglobin neurotoxicity is attenuated by inhibitors of the protein kinase CK2 independent of heme oxygenase activity.

Authors:  Jing Chen-Roetling; Zhi Li; Raymond F Regan
Journal:  Curr Neurovasc Res       Date:  2008-08       Impact factor: 1.990

2.  BAD contributes to RAF-mediated proliferation and cooperates with B-RAF-V600E in cancer signaling.

Authors:  Lisa Polzien; Angela Baljuls; Marco Albrecht; Mirko Hekman; Ulf R Rapp
Journal:  J Biol Chem       Date:  2011-02-11       Impact factor: 5.157

3.  Identification of novel in vivo phosphorylation sites of the human proapoptotic protein BAD: pore-forming activity of BAD is regulated by phosphorylation.

Authors:  Lisa Polzien; Angela Baljuls; Ulrike E E Rennefahrt; Andreas Fischer; Werner Schmitz; Rene P Zahedi; Albert Sickmann; Renate Metz; Stefan Albert; Roland Benz; Mirko Hekman; Ulf R Rapp
Journal:  J Biol Chem       Date:  2009-08-10       Impact factor: 5.157

Review 4.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

Review 5.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

6.  Casein kinase II contributes to the synergistic effects of BMP7 and BDNF on Smad 1/5/8 phosphorylation in septal neurons under hypoglycemic stress.

Authors:  Florence Chaverneff; John Barrett
Journal:  J Neurochem       Date:  2009-02-13       Impact factor: 5.372

7.  Yeast surviving factor Svf1 as a new interacting partner, regulator and in vitro substrate of protein kinase CK2.

Authors:  Maciej Masłyk; Elzbieta Kochanowicz; Rafał Zieliński; Konrad Kubiński; Ulf Hellman; Ryszard Szyszka
Journal:  Mol Cell Biochem       Date:  2008-02-12       Impact factor: 3.396

8.  Dephosphorylation of Centrins by Protein Phosphatase 2C α and β.

Authors:  Marie-Christin Thissen; Josef Krieglstein; Uwe Wolfrum; Susanne Klumpp
Journal:  Res Lett Biochem       Date:  2009-07-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.